Beijing Succeeder Technology Inc (688338) - Total Liabilities

Latest as of September 2025: CN¥81.48 Million CNY ≈ $11.92 Million USD

Based on the latest financial reports, Beijing Succeeder Technology Inc (688338) has total liabilities worth CN¥81.48 Million CNY (≈ $11.92 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Beijing Succeeder Technology Inc generate cash to assess how effectively this company generates cash.

Beijing Succeeder Technology Inc - Total Liabilities Trend (2016–2024)

This chart illustrates how Beijing Succeeder Technology Inc's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Beijing Succeeder Technology Inc to evaluate the company's liquid asset resilience ratio.

Beijing Succeeder Technology Inc Competitors by Total Liabilities

The table below lists competitors of Beijing Succeeder Technology Inc ranked by their total liabilities.

Company Country Total Liabilities
Deutsche Rohstoff AG
XETRA:DR0
Germany €312.78 Million
Chengdu Tianjian Technology Co Ltd
SHE:002977
China CN¥102.11 Million
NIIT LEARNING SYSTEMS LTD
NSE:NIITMTS
India Rs12.34 Billion
Abm Investama Tbk
JK:ABMM
Indonesia Rp1.22 Billion
Waterdrop Inc ADR
NYSE:WDH
USA $1.54 Billion
Kforce Inc.
NYSE:KFRC
USA $241.03 Million
Shenzhen RoadRover Technology Co Ltd
SHE:002813
China CN¥257.39 Million
Beijing AriTime Intelligent Control Co Ltd
SHG:600560
China CN¥1.37 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Beijing Succeeder Technology Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Beijing Succeeder Technology Inc market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 17.24 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.05 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.05 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Beijing Succeeder Technology Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Beijing Succeeder Technology Inc (2016–2024)

The table below shows the annual total liabilities of Beijing Succeeder Technology Inc from 2016 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥102.46 Million
≈ $14.99 Million
-3.35%
2023-12-31 CN¥106.01 Million
≈ $15.51 Million
-1.34%
2022-12-31 CN¥107.44 Million
≈ $15.72 Million
+70.87%
2021-12-31 CN¥62.88 Million
≈ $9.20 Million
+38.77%
2020-12-31 CN¥45.31 Million
≈ $6.63 Million
-12.86%
2019-12-31 CN¥52.00 Million
≈ $7.61 Million
+9.97%
2018-12-31 CN¥47.28 Million
≈ $6.92 Million
+9.91%
2017-12-31 CN¥43.02 Million
≈ $6.29 Million
-15.43%
2016-12-31 CN¥50.87 Million
≈ $7.44 Million
--

About Beijing Succeeder Technology Inc

SHG:688338 China Medical Devices
Market Cap
$475.74 Million
CN¥3.25 Billion CNY
Market Cap Rank
#12823 Global
#4005 in China
Share Price
CN¥30.63
Change (1 day)
+1.83%
52-Week Range
CN¥23.58 - CN¥35.81
All Time High
CN¥126.75
About

Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. The company offers coagulation testers, hemorheology testers, erythrocyte sedimentation testers, platelet aggregation testers, diagnostic reagents, quality control products. Its products are used in the prevention, screening, diagnosis, and… Read more